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Abstract: 
Transition metal complexes with different ligand systems 
have been developed. Majority of them are derived from 
heteroaromatic cycles and Schiff bases of variety of 
aromatic aldehydes, diketones with amino acids, 
polyamines, N-aromatic cycles and ethylenediamines. 
Metal complexes of Schiff bases are used as polymers, 
dyes and in various biological systems. They show 
antimicrobial activity and can be used as suitable drug to 
treat bacterial and fungal infections. Most of the Cu, Ni 
and Co complexes are also capable of binding and 
cleaving DNA.  
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1. Introduction 
Metal complexes have always intrigued chemists since their 
inception. Though they would have questioned elementary 
bonding theory in their infancy, today their applications are 
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multifarious. A paradigm shift was experienced in medicinal 
chemistry, which is based on organic compounds, due to 
serendipitous discovery of cis-platin’s antitumor property. Since 
then, chemists are engrossed in discovering novel metal complexes 
with medicinal properties to tackle diseases which always battle 
with human beings to gain an upper hand. Metal coordinated 
ligand’s 3-dimensional orientation helps in specific molecule 
recognition. Thus the interaction of metal complexes with 
biomolecules is different when compared to that of classic drugs. 
Today gold and platinum complexes are already in the market 
serving as antiarthritic and antitumor drugs respectively, yet in- 
depth structure activity relationship (SAR) investigations are 
needed, to develop metal based drugs with improved 
pharmacological properties. Ligands can also be tailored for 
enhanced specificity. Diversity of transition metal complexes with 
medicinal properties are being reported, among which many are 
centered at metal complexes derived from Schiff bases. This is 
because of their easy synthesis, good donor abilities and 
established medicinal properties. Schiff base compounds find 
application as antibacterial, antifungal and antitumor drugs. 
1.1 History of metallodrugs 
Barnett Rosenberg, a biophysicist in Michigan State University, 
accidently discovered cis-platin. He was studying the effect of 
applied electric field on the growth of E.Coli cells, in order to prove 
that spindle fiber formation gets perturbed during cell division. 
Instead he observed cell elongation without cell division. Later he 
diagnosed that platinum from the electrodes, which he used to 
apply electric field, had dissolved in the buffer containing 
ammonium chloride forming [Pt(NH3)2Cl2] complex,  which caused 
cell elongation. 
      The in vivo studies of the compound showed necrosis of tumor 
in rats. This initiated cis-platin, a metal complex to be used as a 
drug in the treatment of cancer and the search for new complexes 
with better pharmacological properties began and is continuing [1]. 
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1.2 Theory of metal complex toxicity 
Ab initio studies on drugs have proved that, lipophilic character of 
drugs plays an important role in its medicinal property, as 
phospholipid bilayered cell membrane is selectively permeable. 
One has to consider this property while developing metal complex 
based drugs. According to overtone’s concept of cell permeability, 
the lipophilic cell membrane permits the passage of only lipid 
soluble materials, which makes liposolubility as an important 
factor for controlling the microbial activity. This has been 
emphasized in Tweedy’s chelation theory [2]. 
 1.3 Chelation theory 
On chelation of ligand to the metal, the polarity of the metal ion is 
reduced to a great extent due to the overlap of the ligand orbital 
with the metal orbital and there is partial sharing of the positive 
charge of the metal ion with donor atom and increases the 
delocalization of pi-electrons over the chelate ring. Thus chelation 
enhances the lipophilic character of the central metal atom, which 
subsequently favors its permeation through the lipid layers of the 
cell membrane and enhances the penetration of the complexes into 
the lipid membrane, thereby blocking the metal binding sites in the 
enzymes of the microorganism. Many in vitro studies have shown 
the inhibition of enzyme activities in the presence of transition 
metal complexes [3], [4]. 
Inhibition of enzymes can disturb the respiration process, cell 
homeostasis and thus block the synthesis of proteins which restricts 
the further growth of the organisms. Moreover metal complexes 
easily undergo redox reactions and ligand substitutions, which 
allow them to participate in biological redox chemistry and interact 
with bio-molecules [5], [6].  
Many transition metal complexes with different ligand systems 
have been developed, which show antimicrobial, antitumor (DNA 
binding and cleavage) properties, majority of them being derived 
from heteroaromatic cycles and Schiff bases of variety of aromatic 
aldehydes and amines. 
 





2. Schiff Bases 
The biological activity of chelating ligands having N, S and O as 
donor atoms have been studied due to their different metal binding 
modes. The metal ions alter or enhance the activity of the 
biologically active compounds on complexation [7]. Copper 
complexes of iminodiacetic acid and diimines have the ability of 
cleaving double–stranded DNA, by both oxidative and hydrolytic 
cleavage mechanisms [8]. 
 
3. Schiff base with Heterocyclic Group 
Many synthetic compounds with quinoline derivatives were found 
to have pharmacological properties [9]. Drugs containing quinoline 
are known to act as antimalarials [10] [11]. Co(II) and Ni(II) 
complexes of Quinolino Schiff bases were also found to have 
antimicrobial properties[12]. 
Schiff base and their complexes have showed appreciable 
antibacterial and antifungal activity. Tumor growth is also found to 
be inhibited by some Schiff base complexes. Cobalt complexes of 
reduced N,N’-o-Phenylene bis (salicylideneimine) have showed 
significant growth inhibition of yeasts and fungi of the genus 
Scedosporium[13]. 
Cu(II), Ni(II) and VO(II) complexes of Schiff base ligands derived 
from indole derivatives have showed significant antimicrobial 
activity against pathogens in comparison to the ligands which 
showed no activity prior complexation to metals[14]. Co(II), Ni(II), 
Cu(II), Mn(II), Fe(II) complexes of isatin derivatives have been 
screened for their in-vitro antibacterial activities[15]. Complexes of 
various Schiff base ligands derived from aminoantipyrine had high 
antimicrobial activities and were found to cleave DNA [16-19]. 
4. Schiff Base Analogues of Amino Acids 
Schiff bases behave as chelating ligands in coordination chemistry 
[20]. They are also used in catalysis, anti-oxidative activity and as 
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medicines [21]. Amino acid Schiff bases are very effective metal 
ligands and their metal complexes act as models for numerous 
biological systems [22]. These are also involved in numerous 
biochemical reactions which are catalyzed by enzymes [23]. Many 
of them serve as models for the study of pyridoxal (PLP)-amino 
acid Schiff bases which are involved in many metabolic pathways. 
[25]. 
Amino acid Schiff bases and their first row transition metal 
complexes exhibit antifungal, antibacterial, antiviral and 
antitubercular activity [24]. Most of these complexes interact with 
DNA through intercalative binding modes [26]. 
2-nitrobenzaldehyde-glycine and 2-nitrobenzaldehyde methionine 
Schiff base was coordinated with Co(II), Ni(II) and Cu(II) [27]. The 
metal chelates possessed reasonable antimicrobial potential. 
Indole derivatives are known to show variety of biological 
activities such as CNS depressant, anticancerous, antibiotic, 
antihistamine, anticonvulsants, etc [28]. Antimicrobial activity of 
unsymmetrical Schiff bases of indole 3-carboxaldehyde with 
different amino acids like histidine, glutamic acid, aspartic acid, 
valine and leucine and amino acid analogues such as 2-
aminophenol, 2-aminophenol-4-sulphonic acid, 1-amino-2- 
naphthol-4 sulphonic acid have been studied[29]. Co(II), Ni(II) and 
Cu(II) complexes of Schiff base ligand formed from glycylglycine 
and indole-3-carboxaldehyde were also investigated[30]. The Cu(II) 
complexes were found to possess higher bacterial and fungal 
properties than the other metal complexes and ligands. 
5. DNA–metal Complex Interactions 
It is now well established that DNA is the master molecule behind 
cell homeostasis and regulation. In tumor cells, cell division is 
uncontrolled leading to cancer. Various biological experiments 
suggest that DNA is the primary intracellular target of an 
anticancer drug because the interaction between this molecule and 
DNA can cause DNA damage in cancer cells blocking the irregular 
division of cancer cells and resulting in apoptosis [31], [32].  





Cis-platin suffers from the major draw backs of nephrotoxicity, 
neurotoxicity and intravenous administration [33]. These 
drawbacks have stimulated an extensive search for other tumor-
inhibiting complexes of bioessential transition metals like copper 
and iron with improved pharmacological properties. Investigations 
are going on for molecularly targeted metal-based anticancer drugs 
with high specificity versus cytotoxic and broad-spectrum agents. 
The interaction of metal complexes with DNA is the most studied 
aspect of antitumor metal drugs because only then a chemist will 
be able to develop better drugs with enhanced medicinal 
properties. So the SAR is of first importance. The possible metal 
complex-DNA interactions are DNA binding and DNA cleavage. 
5.1 DNA binding 
Metal complexes can bind to DNA in the following ways: 
a. Coordination of the DNA bases to the metal atom 
Purines and pyrimidines are the building blocks of DNA. 
The nitrogen atom in these compounds is a good donor 
towards transition metals. This type of interaction can 
happen through the major or the minor groove of DNA [34-
36]. 
  
b. Intercalation between the stacked base pairs of DNA from 
the major groove side.  
Metal complexes with ligands such as fused ring organic 
heterocycles or polyaromatic planar hydrocarbons can 
efficiently lodge themselves in between the stacked base 
pairs [37]. 
 
c. Electrostatic interaction with DNA  
DNA is a negatively charged molecule due to the presence 
of phosphate groups. This inherent property of DNA is 
utilized in electrophoresis - a separation technique. The 
chances of electrostatic interaction of ligands with oxygen of 
phosphate groups or with nitrogen of the bases are high. 
Hydrogen bonding between the coordinated ligand and the 
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oxygen of the sugar phosphate back bone is also possible 
[38-40]. 
The two modes of binding (a&b) largely depend on the nature of 
conformation of DNA and structural properties, orientation of the 
ligands of metal complexes [25] [41] [42]. 
Some complexes show high avidity towards DNA. This may be due 
to synergistic contribution of all of the three(a,b&c) mentioned 
above and the best illustration in this case is Ru(phen)3 complex, as 
it has high affinity towards DNA and  binds by all the above said 
modes. One planar heterocyclic ring can intercalate with DNA, 
while the other can enter into a hydrophobic interaction with the 
minor groove and also involve in H-bonding with phosphate 
moieties of the sugar back bone. Such complexes are robust models, 
to design and develop metal complexes with desired properties 
[43]. 
Binding of the complexes can cause physical alterations like 
conversion of the super coiled form of DNA to the relaxed form. 
Many investigators have proposed that, on binding DNA, many 
metal complexes are found to inhibit the enzymes involved in DNA 
duplication, like topoisomerases (invitro), which may stall the 
DNA duplication in tumor cells. [44-47]. 
5.2. DNA cleavage 
The second type of DNA-metal complex interaction is cleavage of 
DNA. DNA cleavage is an important property of transition metal 
complex based antitumor drugs. As these complexes exhibit slicing 
of DNA analogous to biological DNA cleavers – Nucleases, they 
are called Artificial Nucleases.  
5.2.1 Types of cleavage 
5.2.1.1 Redox cleavage 
Metal complexes of copper can easily undergo redox reactions and 
generate reactive oxygen species (ROS) like superoxides, hydroxyl 
radicals or singlet oxygen. These oxidizing intermediates can cleave 
DNA. However generation of these reactive intermediates can be 
assisted chemically or in presence of light. 





In chemically assisted DNA cleavage, oxidants like hydrogen 
peroxide can interact with copper complexes to generate hydroxyl 
radicals which in turn oxidize nucleotides of DNA [48 - 50]. 
In photo chemically assisted DNA cleavage, metal complexes are 
photo chemically excited to their higher energy states, which 
suffers an energy transfer to the triplet state, which can activate 
oxygen from its stable triplet state 3∑g to its toxic singlet state 1Δg 
[51]. 
Various metal complexes are investigated for their DNA binding 
and cleaving properties. Copper complexes of different amino acids 
like alanine [52], threonine [53], l-leucine/isoleucine 54],  
phenylalanine [55], proline [56],  methycystein [57], glutamine [58]  
have been synthesized and DNA cleavage properties are studied. It 
is proposed that DNA is cleaved by the reactive oxygen species -
OH●, generated in the presence of H2O2 [44], [59], [60]. 
Transition metal complexes of Schiff bases of different  aromatic, 
heteroaromatic aldehydes like, salicylaldehyde [61], pyridine 
carboxaldehyde [62], indole carboxaldehyde [63], oxo-quinoline-3-
carbaldehyde [64] and amines like 2-aminobenzothiazole [65], 
aminomethylthiophene [66] and antipyrine [16], [18] were 
synthesized and their DNA binding cleavage abilities have been 
studied. 
5.2.1.2. Hydrolytic cleavage 
Coordination of metal complex to sugar phosphate backbone can 
cause hydrolysis of phosphodiester bond by polarizing P-O bond. 
Coordinated nucleophile can also react with phosphate groups 
leading to DNA cleavage [75] [76]. The effect of extended fused 
cycles [37], functional group substitution of ligands [70], planarity 
of cycles [77],  [78], chirality [79] and orientation of ligands on 
metal assisted DNA binding have been investigated[24]. 
6. Schiff Bases of Different Amino Acids 
Schiff bases of different amino acids like valine have been 
synthesized and their DNA binding and cleavage abilities have 
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been investigated [24], [44] ,[67-73], prioritizing selective DNA 
binding and site specific DNA cleavage [74].  
Fused planar aromatic cycles are studied for DNA cleavage abilities 
worldwide because planar aromatic cycles show good DNA 
binding ability. Copper is a good lewis acid and can take part in 
redox chemistry and efficient in generating ROS  like O2-, OH●, O2 
which can cleave  DNA [48-58]. 
7. Conclusion 
Metal complexes are next generation drugs. Intense and dedicated 
research is required for deciphering the metal complex’s 
mechanism behind pharmacological properties and interactions 
with biological systems. Toxicity, metabolism and excretion of 
metallodrugs have to be studied thoroughly. Novel metal 
complexes may find place in DNA finger printing and in 
spectroscopic probing of biomolecules in future. A ray of hope is 
that these metal complex drugs may tackle the issue of multi drug 
resistance of pathogens and can be an efficient antitumor drug. 
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